| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | -% | Small Molecule | Oncology | ||
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | -% | Small Molecule | Oncology | ||
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | -% | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
Utah Medical Products, Inc.$65.21
-0.93 (-1.41%)
Market Cap
205.40 M
EPS
3.38
P/E Ratio
19.09 $
Value Trade
540.84 K
SEC Financials
Q1 2026Dilution Risk
Revenue
8.72 M
R&D Expenses
154.00 K
Operating CF
3.11 M
Total Assets
124.38 M
Total Liabilities
4.01 M
Equity
120.37 M
D/E Ratio
12,345
2.01 %
Week
-7.26 %
1 Month
-2.9 %
3 Month
19.82 %
6 Month
-26.66 %
5 Year
5,854.74 %
All Time
Cash Data
Cash Position
87.41 M
Monthly Burn
-
Runway
12,345 mo
Burn Trend
StableSEC Filing
May 12, 2026
Overview
Volume
16.50 K
52 Week Range
52 - 71.81
% held by Insiders
7.18 %
% held by Institutions
71.41 %
Enterprise Value
118.21 M
Total Shares
3.18 M
Short %
3.82 %
Float Shares
2.96 M
Company Description
locked
Upcoming Catalyst
Drug Pipeline Intelligence
Clinical Trial Results
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | |||
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | |||
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in UTMD
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
Utah Medical Products, Inc. (UTMD) Analyst Ratings & Price Targets
Symbol
Firm
Rating
Action
Price Target
Upside
date
UTMD
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
UTMD
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
UTMD
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
UTMD Stock Forecast & Analyst Consensus
BUY
Analyst Ratings
Buy65.0%
Hold25.0%
Sell10.0%
Price Target Trend
Average$24.00
Low$18.00
High$32.00
UTMD Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
UTMDUtah Medical Products, Inc. Reports Financial Performance for First Quarter 2026 Contact: Brian Koopman (801) 566-1200
Utah Medical Products, Inc. reported its financial performance for the first quarter of 2026, revealing a 10.2% decrease in sales compared to the same quarter in 2025. The company experienced declines across various financial metrics, including net income and gross profit, primarily due to the loss of sales to a major distributor in China. However, the gross profit margin improved from the previous year. Cash equivalent balances showed a positive trend, increasing by $4.1 million year-over-year, despite the overall decline in sales.
Read more →UTMDUtah Medical Products, Inc. Announces Quarterly Dividend - February 4, 2026
Utah Medical Products, Inc. has announced a quarterly cash dividend of $0.31 per share, reflecting a 1.6% increase from the previous year. The dividend will be payable on April 3, 2026, to stockholders of record by March 17, 2026. The company focuses on developing medical devices for women's health and has a global presence.
Read more →UTMDUTMD Reports Year 2025 and Fourth Quarter Financial Performance Contact: Brian Koopman (801) 566-1200
Utah Medical Products, Inc. (UTMD) reported lower than projected financial performance for 2025, with significant declines in revenue and net income compared to the previous year. Despite facing challenges, the company managed to maintain strong profit margins and increased its cash balance to $85.8 million, aided by repurchasing shares and paying dividends. The reduction in revenue is largely attributed to declines in OEM sales and issues with OUS distributors. Legal and financial challenges also contributed to diminished operating income margins for the year.
Read more →UTMDUtah Medical Products, Inc. Appoints Director and Increases Quarterly Dividend Contact: Brian Koopman
Utah Medical Products, Inc. has appointed Kevin C. Timken to its Board of Directors, recognizing his extensive experience as the company's outside legal counsel. The Board also announced a 1.6% increase in the quarterly cash dividend to $0.31 per share, payable on January 5, 2026. This strategic move is expected to enhance the company's governance and financial health. Utah Medical Products focuses on developing medical devices for women's and infants' healthcare, maintaining a strong presence in over a hundred countries.
Read more →UTMDUTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2025 Contact: Brian Koopman (801) 566-1200
Utah Medical Products, Inc. (UTMD) reported a decline in third quarter and nine-month financial performance for 2025, primarily attributed to global trade uncertainties and the cancellation of orders by international distributors. Revenues fell by 2% in Q3 and by 7% for the year-to-date period, significantly impacting gross profit and operating income. Despite improvements in domestic sales and a stronger balance sheet, the overall decrease in sales and earnings highlights ongoing challenges faced by the company.
Read more →UTMDUTMD Reports Financial Performance for Second Calendar Quarter and First Half 2025 Contact: Brian Koopman (801) 566-1200
UTMD reported its financial performance for the second quarter and first half of 2025, showing a decrease in revenue compared to the same periods in 2024. The drop in sales was primarily attributed to significant declines in their partnership with PendoTECH, which accounted for the majority of the sales drop. Despite a strong cash position and share repurchases, gross profit margins contracted, impacting overall profitability. Looking forward, UTMD expects continued challenges with PendoTECH sales, which may remain lower throughout the year.
Read more →UTMDUtah Medical Products, Inc. Reports Financial Performance for First Quarter 2025 Contact: Brian Koopman (801) 566-1200
Utah Medical Products, Inc. has reported financial results for the first quarter of 2025, showing a significant decline in sales and profits compared to the previous year. Revenues fell by 14.4%, and net income decreased by 23.1%. The drop in financial performance was largely attributed to a significant decrease in OEM sales to PendoTECH. However, domestic sales excluding PendoTECH grew by 9%, demonstrating potential for recovery in certain market segments.
Read more →UTMDUTMD Reports Year 2024 and Fourth Quarter Financial Performance Contact: Brian Koopman (801) 566-1200
Utah Medical Products, Inc. (Nasdaq: UTMD) reported a significant contraction in its financial performance for 2024, with revenues and net income declining by 19% and 17% respectively compared to the previous year. The stock price saw a decrease of 27%, prompting the company to repurchase over 8% of its shares. Despite these setbacks, UTMD managed to maintain its gross profit margin, attributed to reduced manufacturing personnel. The decline in sales was primarily driven by decreased revenues from key product categories, including the PendoTECH OEM and OUS distributors.
Read more →UTMDUTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2024 Contact: Brian Koopman (801) 566-1200
UTMD has reported its financial performance for the third quarter and the first nine months of 2024, indicating a decline in revenues but improvements in earnings. Specifically, the company's revenues were down by 20% in 3Q 2024 compared to 3Q 2023, leading to a gross profit decrease. However, due to reductions in overhead costs and the absence of certain amortization expenses, operating income margins showed positive growth during this period. The company also faced increased litigation expenses linked to the Filshie product line, affecting its financial outlook.
Read more →UTMDUTMD Reports Audited Year 2023 and Fourth Quarter Financial Performance Contact: Brian Koopman (801) 566-1200
Utah Medical Products, Inc. (UTMD) reported its audited financial performance for the year 2023, indicating a 4% decrease in revenues despite a 1% increase in net income and earnings per share compared to 2022. The financial results align with management's earlier projections, though challenges were present with decreasing sales to their major biopharma OEM customer, leading to diluted operating income margins. A detailed analysis showed domestic U.S. sales dropped by 12%, attributed in part to ongoing supply chain disruptions and litigation costs. Nonetheless, the company ended the year with increased cash reserves and stockholders' equity.
Read more →UTMDUtah Medical Products, Inc. Increases Regular Quarterly Dividend Contact: Brian Koopman
Utah Medical Products, Inc. has announced a 1.7% increase in its regular quarterly cash dividend, now set at thirty cents ($0.30) per share. The dividend will be payable on January 3, 2024, to shareholders recorded by the close of business on December 15, 2023. This decision reflects the company's ongoing commitment to returning value to its shareholders while maintaining a focus on healthcare for women and babies.
Read more →UTMDUTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2023 Contact: Brian Koopman (801) 566-1200
Utah Medical Products, Inc. (UTMD) reported mixed financial results for the third quarter and the first nine months of 2023. While the company met its gross profit margin targets for the nine-month period, it experienced declines in revenues and operating income compared to the previous year. Notably, domestic sales in the U.S. dropped significantly, contributing to the overall decrease in quarterly performance. Despite these challenges, UTMD's net income and cash balance improved, indicating some financial resilience.
Read more →UTMDUTMD Reports Financial Performance for Second Calendar Quarter and First Half 2023 Contact: Brian Koopman (801) 566-1200
Utah Medical Products, Inc. (UTMD) reported its financial results for the second quarter and the first half of 2023, showing a mixed performance. While net income increased by 10% year-over-year, operating income declined by 7.5% due to litigation costs. The company faced challenges in biopharmaceutical OEM sales and domestic sales were hindered by ongoing supply chain issues. Nevertheless, UTMD managed to maintain its gross profit margins amid these difficulties.
Read more →UTMDUtah Medical Products, Inc. Reports Financial Performance for First Quarter 2023 Contact: Brian Koopman (801) 566-1200
Utah Medical Products, Inc. reported its financial performance for the first quarter of 2023, showing an overall positive trend compared to the same period last year. The company's net income saw a notable increase of 19.2%, while earnings per share climbed by 20.2%. Despite a decline in domestic sales by 10%, international sales rose sharply, particularly outside the U.S., which contributed to overall growth. However, an increase in litigation expenses and a slight drop in operating income raised some concerns regarding operational costs.
Read more →UTMDUTMD Reports Audited Year 2022 and Fourth Quarter Financial Performance Contact: Brian Koopman (801) 566-1200
Utah Medical Products, Inc. (UTMD) reported a strong financial performance for the year 2022, exceeding projections despite facing challenges. The company observed a 5% increase in revenues for Q4 and a 7% increase for the full year compared to 2021. Notably, net income and earnings per share saw significant increases of 8-12%. However, domestic sales experienced a decline, and legal costs impacted overall operating income margins.
Read more →UTMDUTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2022 Contact: Crystal Rios (801) 566-1200
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2022 Salt Lake City, Utah - In the third calendar quarter (3Q) of 2022, despite significant cost inflation, supply chain disruption, litigation expenses and negative impact of a stronger U.S. Dollar on
Read more →UTMDUTMD Reports Financial Performance for Second Calendar Quarter and First Half 2022 Contact: Crystal Rios (801) 566-1200
UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2022 Salt Lake City, Utah - UTMD achieved second calendar quarter (2Q) and first half (1H) 2022 financial results better than those anticipated in its beginning of year projections. Currencies in this
Read more →UTMDUtah Medical Products, Inc. Reports Financial Performance for First Quarter 2022 Contact: Crystal Rios (801) 566-1200
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2022 Salt Lake City, Utah - In the first calendar quarter (1Q) of 2022, Utah Medical Products, Inc. (Nasdaq: UTMD) attained financial results consistent with achieving its goals for calendar year 2022.
Read more →UTMDUtah Medical Products, Inc. Announces Quarterly Dividend Contact: Crystal Rios
Utah Medical Products, Inc. Announces Quarterly Dividend Contact: Crystal RiosFebruary 8, 2022 Salt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-nine cents ($.29) per share of com
Read more →UTMDUTMD Reports Audited Year 2021 and Fourth Quarter Financial Performance Contact: Crystal Rios (801) 566-1200
UTMD Reports Audited Year 2021 and Fourth Quarter Financial Performance Salt Lake City, Utah - The fourth calendar quarter (4Q) of 2021 financial results demonstrate Utah Medical Products, Inc.'s (Nasdaq: UTMD's) continuing performance improvement despite many challenges related
Read more →UTMDUtah Medical Products, Inc. Announces Special Dividend Contact: Crystal Rios
Utah Medical Products, Inc. Announces Special Dividend Contact: Crystal Rios November 2, 2021 (801) 566-1200 Salt Lake City, Utah -Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its Board of Directors approved a special cash dividend of two dollars ($2.00) per share
Read more →UTMDUTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2021 Contact: Crystal Rios (801) 566-1200
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2021 Salt Lake City, Utah - The third calendar quarter (3Q) of 2021 financial results continued to demonstrate Utah Medical Products, Inc.'s (Nasdaq: UTMD's) recovery after a time when there were restr
Read more →UTMDUTMD Reports Financial Performance for Second Calendar Quarter and First Half 2021 Contact: Crystal Rios (801) 566-1200
UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2021 Contact: Crystal Rios (801) 566-1200July 22, 2021 Salt Lake City, Utah - The second calendar quarter (2Q) of 2021 financial results were dramatically different from 2Q 2020 because 2Q 2020 result
Read more →UTMDUtah Medical Products, Inc. Reports Financial Performance for First Quarter 2021 Contact: Crystal Rios (801) 566-1200
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2021 Contact: Crystal Rios (801) 566-1200April 22, 2021 Salt Lake City, Utah - Because of the aberration in results which began in March 2020 due to the impact of restrictions on "nonessential" medical
Read more →UTMDUTMD Reports Audited Year 2020 and Fourth Quarter Financial Performance Contact: Crystal Rios (801) 566-1200
UTMD Reports Audited Year 2020 and Fourth Quarter Financial Performance Contact: Crystal Rios (801) 566-1200January 28, 2021 Salt Lake City, Utah -Utah Medical Products, Inc. (Nasdaq: UTMD) reports financial results for the fourth calendar quarter (4Q) which confirms a trend of
Read more →UTMDUtah Medical Products, Inc. Increases Quarterly Dividend Contact: Crystal Rios
Utah Medical Products, Inc. Increases Quarterly Dividend Contact: Crystal RiosNovember 3, 2020 Salt Lake City, Utah -Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-eight and one-half cents ($.285) pe
Read more →UTMDUTMD Reports Financial Performance for Third Quarter and Nine Months of Year 2020 Contact: Crystal Rios (801) 566-1200
UTMD Reports Financial Performance for Third Quarter and Nine Months of Year 2020 Contact: Crystal Rios (801) 566-1200October 27, 2020 Salt Lake City, Utah - For the third calendar quarter (3Q) and first nine months (9M) of 2020, Utah Medical Products, Inc. (Nasdaq: UTMD) repor
Read more →UTMDUTMD Reports Financial Performance for Second Calendar Quarter and First Half 2020 Contact: Crystal Rios (801) 566-1200
UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2020 Contact: Crystal Rios (801) 566-1200July 28, 2020 Salt Lake City, Utah - As many of the gynecology devices provided by Utah Medical Products, Inc. (Nasdaq: UTMD) are used in "nonessential" or "el
Read more →UTMDUtah Medical Products, Inc. Reports Financial Performance for First Quarter 2020 Contact: Crystal Rios (801) 566-1200
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2020 Contact: Crystal Rios (801) 566-1200April 23, 2020 Salt Lake City, Utah - In the first calendar quarter (1Q) of 2020, Utah Medical Products, Inc. (Nasdaq: UTMD) attained results consistent with 1Q
Read more →UTMDUTMD Postpones its 2020 Annual Stockholders' Meeting for Three Months Contact: Crystal Rios
UTMD Postpones its 2020 Annual Stockholders' Meeting for Three Months Contact: Crystal Rios March 23, 2020 (801) 566-1200 Salt Lake City, Utah - As stockholders of Utah Medical Products, Inc. (Nasdaq: UTMD) appreciate, as a result of the recent rapid spread of the COVID-19 (c
Read more →UTMDUTMD Reports Audited Year 2019 and Fourth Quarter Financial Performance Contact: Crystal Rios
UTMD Reports Audited Year 2019 and Fourth Quarter Financial Performance Contact: Crystal Rios January 30, 2020 (801) 566-1200 Salt Lake City, Utah - In the final calendar quarter (4Q) of 2019, Utah Medical Products, Inc. (Nasdaq: UTMD) began to realize accretive profits net of
Read more →UTMDSalt Lake City, Utah Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-eight cents ($.28) per share of common stock payable on
Salt Lake City, Utah Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-eight cents ($.28) per share of common stock payable on January 3, 2020 to shareholders of record at the close of business on Decemb
Read more →UTMDUTMD Reports Financial Performance for Third Quarter and Nine Months of Year 2019 Contact: Crystal Rios (801) 566-1200
UTMD Reports Financial Performance for Third Quarter and Nine Months of Year 2019 Salt Lake City, Utah - In the third calendar quarter (3Q) and first nine months (9M) of 2019, Utah Medical Products, Inc. (Nasdaq: UTMD) attained results which reflect that the Company is likely t
Read more →UTMDUtah Medical Products, Inc. Reports Financial Performance for Second Quarter 2019 Contact: Crystal Rios (801) 566-1200
Utah Medical Products, Inc. Reports Financial Performance for Second Quarter 2019 Contact: Crystal Rios (801) 566-1200 July 30, 2019 Salt Lake City, Utah - In the second calendar quarter (2Q) and first half (1H) of 2019, Utah Medical Products, Inc. (Nasdaq: UTMD) attained resul
Read more →UTMDUtah Medical Products, Inc. Reports Financial Performance for First Quarter 2019 Contact: Crystal Rios (801) 566-1200
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2019 Salt Lake City, Utah - In the first calendar quarter (1Q) of 2019, Utah Medical Products, Inc. (Nasdaq: UTMD) attained results consistent with achieving its financial goals for year 2019 despite a
Read more →UTMDUTMD Reports Audited Year 2018 and Fourth Quarter Financial Performance Contact: Crystal Rios
UTMD Reports Audited Year 2018 and Fourth Quarter Financial Performance Contact: Crystal Rios January 31, 2019 (801) 566-1200 Salt Lake City, Utah - Excluding a large favorable adjustment correcting the U.S. repatriation tax (REPAT) on foreign subsidiary cash and cumulative e
Read more →UTMDSalt Lake City, Utah Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-seven and one-half cents ($.275) per share of common stock payable on
Salt Lake City, Utah Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-seven and one-half cents ($.275) per share of common stock payable on January 3, 2019 to shareholders of record at the close of busin
Read more →UTMDUTAH MEDICAL PRODUCTS, INC. 7043 South 300 West Midvale, Utah 84047 Telephone: 801-566-1200 FAX: 801-566-2062 Nasdaq Symbol: UTMD www.utahmed.com PRESS RELEASE Utah Medical Products, Inc. Reports Financial Performance fo
UTAH MEDICAL PRODUCTS, INC. Telephone: 801-566-1200 Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2018 Salt Lake City, Utah - In the first calendar quarter (1Q) of 2018, Utah Medical Products, Inc. (Nasdaq: UTMD) attained results consistent with a
Read more →UTMDUTMD Reports Audited Financial Performance for Fourth Quarter and Year 2017 Contact: Paul Richins
UTMD Reports Audited Financial Performance for Fourth Quarter and Year 2017 Contact: Paul Richins January 30, 2018 (801) 566-1200 Salt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) concluded an outstanding year in 2017 in which it harvested distribution changes
Read more →UTMDSalt Lake City, Utah Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-seven cents ($.27) per share of common stock payable on
Salt Lake City, Utah Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-seven cents ($.27) per share of common stock payable on January 3, 2018 to shareholders of record at the close of business on Decembe
Read more →UTMDUtah Medical Products, Inc. Reports Financial Performance for Third Quarter 2017 Contact: Paul Richins
Utah Medical Products, Inc. Reports Financial Performance for Third Quarter 2017 Contact: Paul Richins October 24, 2017 (801) 566-1200 Salt Lake City, Utah - In the third calendar quarter (3Q) and first nine months (9M) of 2017, Utah Medical Products, Inc. (Nasdaq: UTMD) achie
Read more →UTMDUtah Medical Products, Inc. Reports Financial Performance for Second Quarter 2017 Contact: Paul Richins
Utah Medical Products, Inc. Reports Financial Performance for Second Quarter 2017 Contact: Paul Richins July 25, 2017 (801) 566-1200 Salt Lake City, Utah - In the second calendar quarter (2Q) and first half (1H) of 2017, Utah Medical Products, Inc. (Nasdaq: UTMD) achieved resu
Read more →UTMDUtah Medical Products, Inc. Reports Financial Performance for First Quarter 2017 Contact: Paul Richins
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2017 Contact: Paul Richins April 25, 2017 (801) 566-1200 Salt Lake City, Utah - In the first calendar quarter (1Q) of 2017, Utah Medical Products, Inc. (Nasdaq: UTMD) achieved results representing a st
Read more →UTMDUTMD Reports Audited Financial Performance for Fourth Quarter and Year 2016 Contact: Paul Richins
UTMD Reports Audited Financial Performance for Fourth Quarter and Year 2016 Contact: Paul Richins January 31, 2017 (801) 566-1200 Salt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) concluded a year in 2016 in which Operating Income (OI) and Earnings Per Share (E
Read more →UTMDUtah Medical Products, Inc. Reports Financial Performance for Third Quarter 2016 Contact: Paul Richins
Utah Medical Products, Inc. Reports Financial Performance for Third Quarter 2016 Contact: Paul Richins October 25, 2016 (801) 566-1200 Salt Lake City, Utah - In the third calendar quarter (3Q) and first nine months (9M) of 2016, Utah Medical Products, Inc.'s (Nasdaq: UTMD) cha
Read more →UTMDUtah Medical Products, Inc. Reports Financial Performance for Second Quarter 2016 Contact: Paul Richins
Utah Medical Products, Inc. Reports Financial Performance for Second Quarter 2016 Contact: Paul Richins July 26, 2016 (801) 566-1200 Salt Lake City, Utah - In the second calendar quarter (2Q) and first half (1H) of 2016, Utah Medical Products, Inc. (Nasdaq: UTMD) continued to
Read more →UTMDUTMD Reports Audited Financial Performance for Fourth Quarter and Year 2015 Contact: Paul Richins
UTMD Reports Audited Financial Performance for Fourth Quarter and Year 2015 Contact: Paul Richins February 2, 2016 (801) 566-1200 Salt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) concluded a financial year in 2015 dominated by changes in foreign currency excha
Read more →UTMDSalt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-six cents ($.26) per share of common stock payable on
Salt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-six cents ($.26) per share of common stock payable on December 30, 2015 to shareholders of record at the close of business on Decem
Read more →UTMDUtah Medical Products, Inc. Reports Financial Performance for Second Quarter 2015 Contact: Paul Richins
Utah Medical Products, Inc. Reports Financial Performance for Second Quarter 2015 Contact: Paul Richins July 23, 2015 (801) 566-1200 Salt Lake City, Utah - In the second calendar quarter (2Q) and first half (1H) of 2015, Utah Medical Products, Inc. (Nasdaq: UTMD) achieved resu
Read more →UTMDUtah Medical Products, Inc. Reports Financial Performance for First Quarter 2015 Contact: Paul Richins
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2015 Contact: Paul Richins April 23, 2015 (801) 566-1200 Salt Lake City, Utah - In the first calendar quarter (1Q) of 2015, Utah Medical Products, Inc. (Nasdaq: UTMD) achieved results representing a so
Read more →UTMDUTMD Reports Financial Performance for Fourth Quarter and Year 2014 Contact: Paul Richins
UTMD Reports Financial Performance for Fourth Quarter and Year 2014 Contact: Paul Richins January 29, 2015 (801) 566-1200 Salt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) concluded another excellent financial year in 2014, exceeding its projections provided in
Read more →UTMDSalt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-five and one half cents ($.255) per share of common stock payable on
Salt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-five and one half cents ($.255) per share of common stock payable on December 30, 2014 to shareholders of record at the close of bu
Read more →UTMDUtah Medical Products, Inc. Reports Financial Performance for Third Quarter 2014 Contact: Paul Richins
Utah Medical Products, Inc. Reports Financial Performance for Third Quarter 2014 Contact: Paul Richins October 23, 2014 (801) 566-1200 Salt Lake City, Utah - In the third calendar quarter (3Q) and first nine months (9M) of 2014, Utah Medical Products, Inc.'s (Nasdaq: UTMD) cha
Read more →UTMDUtah Medical Products, Inc. Reports Financial Performance for Second Quarter 2014 Contact: Paul Richins
Utah Medical Products, Inc. Reports Financial Performance for Second Quarter 2014 Contact: Paul Richins July 24, 2014 (801) 566-1200 Salt Lake City, Utah - In the second calendar quarter (2Q) and first half (1H) of 2014, Utah Medical Products, Inc.'s (Nasdaq: UTMD) changes in
Read more →UTMDUtah Medical Products, Inc. Reports Financial Performance for First Quarter 2014 Contact: Paul Richins
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2014 Contact: Paul Richins April 24, 2014 (801) 566-1200 Salt Lake City, Utah - In the first calendar quarter (1Q) of 2014, Utah Medical Products, Inc. (Nasdaq: UTMD) achieved net income consistent wit
Read more →UTMDUTMD Reports Financial Performance for Fourth Quarter and Year 2013 Contact: Paul Richins
UTMD Reports Financial Performance for Fourth Quarter and Year 2013 Contact: Paul Richins January 30, 2014 (801) 566-1200 Salt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) concluded another excellent financial year in 2013 under difficult conditions. The result
Read more →UTMDSalt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-five cents ($.25) per share of common stock payable on
Salt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-five cents ($.25) per share of common stock payable on December 30, 2013 to shareholders of record at the close of business on Dece
Read more →UTMDUtah Medical Products, Inc. Reports Financial Performance for Third Quarter 2013 Contact: Paul Richins
Utah Medical Products, Inc. Reports Financial Performance for Third Quarter 2013 Contact: Paul Richins October 24, 2013 (801) 566-1200 Salt Lake City, Utah - In the third calendar quarter (3Q) and first nine months (9M) of 2013, Utah Medical Products, Inc.'s (Nasdaq: UTMD) cha
Read more →UTMDUtah Medical Products, Inc. Reports Financial Performance for Second Quarter 2013 Contact: Paul Richins
Utah Medical Products, Inc. Reports Financial Performance for Second Quarter 2013 Contact: Paul Richins July 25, 2013 (801) 566-1200 Salt Lake City, Utah - In the second calendar quarter (2Q) and first half (1H) of 2013, Utah Medical Products, Inc.'s (Nasdaq: UTMD) changes in
Read more →UTMDUtah Medical Products, Inc. Reports Financial Performance for First Quarter 2013 Contact: Paul Richins
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2013 Contact: Paul Richins April 25, 2013 (801) 566-1200 Salt Lake City, Utah - In the first calendar quarter (1Q) of 2013, Utah Medical Products, Inc. (Nasdaq: UTMD) achieved financial results on trac
Read more →UTMDUTMD Reports Financial Performance for Fourth Quarter and Year 2012 Contact: Paul Richins
UTMD Reports Financial Performance for Fourth Quarter and Year 2012 Contact: Paul Richins January 31, 2013 (801) 566-1200 Salt Lake City, Utah - In the fourth calendar quarter (4Q) 2012 and year of 2012, Utah Medical Products, Inc.'s (Nasdaq: UTMD) changes in financial res
Read more →UTMDSalt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-four and one half cents ($.245) per share of common stock payable on
Salt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-four and one half cents ($.245) per share of common stock payable on December 28, 2012 to shareholders of record at the close of bu
Read more →UTMDUtah Medical Products, Inc. Reports Financial Performance for Third Quarter 2012 Contact: Paul Richins
Utah Medical Products, Inc. Reports Financial Performance for Third Quarter 2012 Contact: Paul Richins October 25, 2012 (801) 566-1200 Salt Lake City, Utah - In the third calendar quarter (3Q) and first nine months (9M) of 2012, Utah Medical Products, Inc.'s (Nasdaq: UTMD) cha
Read more →UTMDUtah Medical Products, Inc. Reports Financial Performance for Second Quarter 2012 Contact: Paul Richins
Utah Medical Products, Inc. Reports Financial Performance for Second Quarter 2012 Contact: Paul Richins July 26, 2012 (801) 566-1200 Salt Lake City, Utah - In the second calendar quarter (2Q) and first half (1H) of 2012, Utah Medical Products, Inc.'s (Nasdaq: UTMD) changes in
Read more →UTMDUtah Medical Products, Inc. Reports Financial Performance for First Quarter 2012 Contact: Paul Richins
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2012 Contact: Paul Richins April 25, 2012 (801) 566-1200 Salt Lake City, Utah - In the first calendar quarter (1Q) of 2012, Utah Medical Products, Inc. (Nasdaq: UTMD) achieved substantial growth in r
Read more →UTMDUTMD Reports Financial Performance for Fourth Quarter and Year 2011 Contact: Paul Richins
UTMD Reports Financial Performance for Fourth Quarter and Year 2011 Contact: Paul Richins January 31, 2012 (801) 566-1200 Salt Lake City, Utah - In the fourth calendar quarter (4Q) 2011 and year of 2011, Utah Medical Products, Inc.'s (Nasdaq: UTMD) changes in financial results
Read more →UTMDSalt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-four cents ($.24) per share of common stock payable on
Salt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-four cents ($.24) per share of common stock payable on December 29, 2011 to shareholders of record at the close of business on Dece
Read more →UTMDUtah Medical Products, Inc. Reports Financial Performance for Third Quarter 2011 Contact: Paul Richins
Utah Medical Products, Inc. Reports Financial Performance for Third Quarter 2011 Contact: Paul Richins October 20, 20111 (801) 566-1200 Salt Lake City, Utah - In the third calendar quarter (3Q) and first nine months (9M) of 2011, Utah Medical Products, Inc.'s (Nasdaq: UTMD) ch
Read more →UTMDUtah Medical Products, Inc. Reports Financial Performance for Second Quarter 2011 Salt Lake City, Utah - In the second calendar quarter (2Q) and first half (1H) of 2011, Utah Medical Products, Inc.'s (Nasdaq: UTMD) chang
Utah Medical Products, Inc. Reports Financial Performance for Second Quarter 2011 Salt Lake City, Utah - In the second calendar quarter (2Q) and first half (1H) of 2011, Utah Medical Products, Inc.'s (Nasdaq: UTMD) changes in financial results compared to the same time period in
Read more →UTMDUtah Medical Products, Inc. Reports Financial Performance for First Quarter 2011 Contact: Paul Richins
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2011 Contact: Paul Richins April 28, 2011 (801) 566-1200 Salt Lake City, Utah - As reported earlier, Utah Medical Products, Inc. (Nasdaq:UTMD) acquired Femcare Holdings Limited ("Femcare") of the Unite
Read more →UTMDUtah Medical Products, Inc. Acquires Femcare Group Limited Contact: Paul Richins
Utah Medical Products, Inc. Acquires Femcare Group Limited Salt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) announces it has purchased all of the common shares of Femcare Holdings Limited of the United Kingdom, including its trading subsidiaries, Femcare-Nikomed
Read more →UTMDUtah Medical Products, Inc. Reports Financial Performance for Fourth Quarter and Year 2010 Salt Lake City, Utah - In the fourth calendar quarter (4Q) 2010 and year of 2010, Utah Medical Products, Inc.'s (Nasdaq: UTMD) ch
Utah Medical Products, Inc. Reports Financial Performance for Fourth Quarter and Year 2010 Salt Lake City, Utah - In the fourth calendar quarter (4Q) 2010 and year of 2010, Utah Medical Products, Inc.'s (Nasdaq: UTMD) changes in financial results compared to the same time period
Read more →UTMDSalt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its Board of Directors approved a special cash dividend of ninety-six cents ($.96) per share of common stock payable on
Salt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its Board of Directors approved a special cash dividend of ninety-six cents ($.96) per share of common stock payable on December 30, 2010 to shareholders of record at the close of business on Decembe
Read more →UTMDUtah Medical Products, Inc. Reports Financial Performance for Third Quarter 2010 Salt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) reports lower sales, improved profit margins and a stronger ending balanc
Utah Medical Products, Inc. Reports Financial Performance for Third Quarter 2010 Salt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) reports lower sales, improved profit margins and a stronger ending balance sheet for the third calendar quarter (3Q) 2010 compared t
Read more →UTMDUtah Medical Products, Inc. Reports Financial Performance for Second Quarter 2010 Salt Lake City, Utah - In the second calendar quarter (2Q) and first half (1H) of 2010, Utah Medical Products, Inc.'s (Nasdaq: UTMD) chang
Utah Medical Products, Inc. Reports Financial Performance for Second Quarter 2010 Salt Lake City, Utah - In the second calendar quarter (2Q) and first half (1H) of 2010, Utah Medical Products, Inc.'s (Nasdaq: UTMD) changes in financial results compared to the same time period in
Read more →UTMDUtah Medical Products, Inc. Reports Financial Performance for First Quarter 2010 Salt Lake City, Utah - In the first calendar quarter (1Q) of 2010, Utah Medical Products, Inc. (Nasdaq:UTMD) achieved revenues and net cash
Medical Products, Inc. Reports Financial Performance for First Quarter City, Utah - In the first calendar quarter (1Q) of 2010, Utah Medical Products, Inc. (Nasdaq:UTMD) achieved revenues and net cash provided by operations virtually the same as in 1Q 2009. Profitability, howe
Read more →UTMDSalt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) announces that two FDA investigators have concluded a full QSIT inspection used to assess a medical device manufacturer's compliance with the Quality Syst
City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) announces that two FDA investigators have concluded a full QSIT inspection used to assess a medical device manufacturer's compliance with the Quality System Regulation (QSR) and related regulations. The inspectional proce
Read more →UTMDUtah Medical Products, Inc. Reports Financial Performance for Fourth Quarter and Year 2009 Salt Lake City, Utah - In the fourth calendar quarter (4Q) 2009 and year of 2009, Utah Medical Products, Inc.'s (Nasdaq: UTMD) ch
Medical Products, Inc. Reports Financial Performance for Fourth Quarter and Year City, Utah - In the fourth calendar quarter (4Q) 2009 and year of 2009, Utah Medical Products, Inc.'s (Nasdaq: UTMD) changes in financial results compared to the same time period in the prior cale
Read more →UTMDSalt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-three and one-half cents ($.235) per share of common stock payable on
City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-three and one-half cents ($.235) per share of common stock payable on December 30, 2009 to shareholders of record at the close of business
Read more →UTMDUtah Medical Products, Inc. Reports Financial Performance for Third Quarter 2009 Salt Lake City, Utah - In the third calendar quarter (3Q) 2009 and three quarters year-to-date, or nine months (9M) of 2009, Utah Medical P
Medical Products, Inc. Reports Financial Performance for Third Quarter City, Utah - In the third calendar quarter (3Q) 2009 and three quarters year-to-date, or nine months (9M) of 2009, Utah Medical Products, Inc.'s (Nasdaq: UTMD) changes in financial results compared to the s
Read more →UTMDSalt Lake City, Utah - In the second calendar quarter (2Q) and first half (1H) of 2009, Utah Medical Products, Inc.'s (Nasdaq: UTMD) changes in financial results compared to the same time period in the prior calendar yea
City, Utah - In the second calendar quarter (2Q) and first half (1H) of 2009, Utah Medical Products, Inc.'s (Nasdaq: UTMD) changes in financial results compared to the same time period in the prior calendar year were as 2Q (April - June) 1H (January - June) Sales: (11%) ( 9%)
Read more →UTMDSalt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq:UTMD) achieved its targeted profit margins for First Quarter (1Q) 2009, compared to the prior quarter (4Q 2008) and same quarter in the prior year (1Q 2008): 1Q
City, Utah - Utah Medical Products, Inc. (Nasdaq:UTMD) achieved its targeted profit margins for First Quarter (1Q) 2009, compared to the prior quarter (4Q 2008) and same quarter in the prior year (1Q 2008): 1Q 2009 (JAN - MAR) 4Q 2008 (OCT - DEC) 1Q 2008 (JAN - MAR) Gross Pro
Read more →UTMDSalt Lake City, Utah - Utah Medical Products, Inc.'s (Nasdaq: UTMD) financial results for fourth quarter 2008 (4Q08) were negatively affected by the downward economic pressure that is also being reported by other compani
City, Utah - Utah Medical Products, Inc.'s (Nasdaq: UTMD) financial results for fourth quarter 2008 (4Q08) were negatively affected by the downward economic pressure that is also being reported by other companies in the medical device quarter (4Q08), both domestic direct sales
Read more →UTMDSalt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-three cents ($.23) per share of common stock payable on
City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-three cents ($.23) per share of common stock payable on January 5, 2009 to shareholders of record at the close of business on December 16,
Read more →UTMDSalt Lake City, Utah - In the third calendar quarter (3Q) and three quarters year-to-date, or nine months (9M), of 2008, Utah Medical Products, Inc.'s (Nasdaq: UTMD) changes in financial results compared to the same time
City, Utah - In the third calendar quarter (3Q) and three quarters year-to-date, or nine months (9M), of 2008, Utah Medical Products, Inc.'s (Nasdaq: UTMD) changes in financial results compared to the same time period in the prior calendar year were as follows: 3Q (July - Se
Read more →UTMDSalt Lake City, Utah - In the second calendar quarter (2Q) and first half (1H) of 2008, Utah Medical Products, Inc.'s (Nasdaq: UTMD) changes in financial results compared to the same time period in the prior calendar yea
City, Utah - In the second calendar quarter (2Q) and first half (1H) of 2008, Utah Medical Products, Inc.'s (Nasdaq: UTMD) changes in financial results compared to the same time period in the prior calendar year were as 2Q ( April - June) 1H ( January - June) Sales: (1%) (2%)
Read more →UTMDSalt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq:UTMD) reports that it achieved the following profit margins for First Quarter (1Q) 2008: 1Q 2008 (January - March) Gross Profit Margin (gross profits/ sales): 54
City, Utah - Utah Medical Products, Inc. (Nasdaq:UTMD) reports that it the following profit margins for First Quarter (1Q) 2008: 1Q 2008 (January - March) Gross Profit Margin (gross profits/ sales): 54.4% Operating Profit Margin (operating profits/ sales): 36.9% Net Profit Mar
Read more →UTMDSalt Lake City, Utah - Utah Medical Products, Inc.'s (Nasdaq: UTMD) financial results for 2007 were dragged down by a weak fourth quarter (4Q). A comparison of 4Q 2007 results to 4Q 2006 is accentuated by the fact that 4
City, Utah - Utah Medical Products, Inc.'s (Nasdaq: UTMD) financial results for 2007 were dragged down by a weak fourth quarter (4Q). A comparison of 4Q 2007 results to 4Q 2006 is accentuated by the fact that 4Q 2006 was the best quarter of 2006 in both sales and earnings per
Read more →UTMDSalt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-two and one-half cents ($.225) per share of common stock payable on
City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its of Directors approved a quarterly cash dividend of twenty-two and one-half ($.225) per share of common stock payable on January 3, 2008 to shareholders record at the close of business on December 14, 20
Read more →UTMDSalt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq:UTMD) reports that for the third calendar quarter (3Q) of 2007 compared to 3Q 2006, consolidated sales were up 1%, gross profits were the same, operating profits
City, Utah - Utah Medical Products, Inc. (Nasdaq:UTMD) reports that for the third calendar quarter (3Q) of 2007 compared to 3Q 2006, consolidated sales up 1%, gross profits were the same, operating profits were down 1%, net income was up 1%, and earnings per share (eps) were u
Read more →UTMDSalt Lake City, Utah - In the second calendar quarter (2Q) of 2007, Utah Medical Products, Inc.'s (Nasdaq: UTMD) changes in financial results compared to the same time period in the prior calendar year were as follows: 2
City, Utah - In the second calendar quarter (2Q) of 2007, Utah Medical Products, Inc.'s (Nasdaq: UTMD) changes in financial results compared to the same time period in the prior calendar year were as follows: 2Q (April - June) 1H (January - June) Sales: (1%) - Gross Profi
Read more →UTMDSalt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq:UTMD) reports changes in measures of financial performance for First Quarter (1Q) 2007 compared to 1Q 2006, as follows: Sales n/c Gross Profits ( 2%) Operating P
City, Utah - Utah Medical Products, Inc. (Nasdaq:UTMD) reports changes in measures of financial performance for First Quarter (1Q) 2007 compared to Sales n/c Gross Profits ( 2%) Operating Profits +2% Earnings before Taxes (EBT) ( 2%) Net Income ( 4%) Earnings per Share (EPS) (
Read more →UTMDSalt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-two cents ($.22) per share of common stock payable on
City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its of Directors approved a quarterly cash dividend of twenty-two cents ($.22) share of common stock payable on April 4, 2007 to shareholders of record close of business on March 15, 2007. This is a five pe
Read more →UTMDSalt Lake City, Utah - In the fourth quarter (4Q) of 2006, Utah Medical Products, Inc.'s (Nasdaq: UTMD) consolidated sales were up 5%, gross profits up 3%, operating profits up 32%, net income up 9% and earnings per shar
City, Utah - In the fourth quarter (4Q) of 2006, Utah Medical Products, Inc.'s (Nasdaq: UTMD) consolidated sales were up 5%, gross profits up 3%, operating profits up 32%, net income up 9% and earnings per share (eps) up 11%, compared full calendar year of 2006, UTMD's consoli
Read more →UTMDSalt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-one cents ($.21) per share of common stock payable on
City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its of Directors approved a quarterly cash dividend of twenty-one cents ($.21) share of common stock payable on January 4, 2007 to shareholders of record the close of business on December 14, 2006. This is
Read more →UTMDSalt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq:UTMD) reports that for the third calendar quarter (3Q) of 2006 compared to 3Q 2005, consolidated sales were the same, gross profits were down 1%, operating profi
City, Utah - Utah Medical Products, Inc. (Nasdaq:UTMD) reports that for the third calendar quarter (3Q) of 2006 compared to 3Q 2005, consolidated sales the same, gross profits were down 1%, operating profits were up 34%, net income was up 12%, and earnings per share (eps) were
Read more →UTMDSalt Lake City, Utah - On
City, Utah - On July 15, 2005, Utah Medical Products, Inc. (Nasdaq:UTMD) filed an administrative claim with the Department of Health and Human Services (HHS), the parent of the U.S. Food & Drug Administration (FDA), under the Federal Tort Claims Act (FTCA), alleging abuse of p
Read more →UTMDSalt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty cents ($.20) per share of common stock payable on
City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its of Directors approved a quarterly cash dividend of twenty cents ($.20) per of common stock payable on October 4, 2006 to shareholders of record at the close of business on September 15, 2006. This is a
Read more →UTMDSalt Lake City, Utah - In the second calendar quarter (2Q) of 2006, Utah Medical Products, Inc.'s (Nasdaq: UTMD) consolidated sales were up 4%, gross profits up 1%, operating profits up 5%, net income up 9%, and earnings
City, Utah - In the second calendar quarter (2Q) of 2006, Utah Medical Products, Inc.'s (Nasdaq: UTMD) consolidated sales were up 4%, gross profits up 1%, operating profits up 5%, net income up 9%, and earnings per share (eps) up compared to 2Q 2005. 2Q 2006 sales to 2Q 2005
Read more →UTMDSalt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its Board of Directors approved a quarterly cash dividend of nineteen cents ($.19) per share of common stock payable on
City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its of Directors approved a quarterly cash dividend of nineteen cents ($.19) share of common stock payable on July 5, 2006 to shareholders of record at close of business on June 16, 2006. This is a six perc
Read more →UTMDSalt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq:UTMD) reports that all primary income statement measures of financial performance in First Quarter (1Q) 2006 increased compared to 1Q 2005, according to the foll
City, Utah - Utah Medical Products, Inc. (Nasdaq:UTMD) reports that all primary income statement measures of financial performance in First Quarter (1Q) increased compared to 1Q 2005, according to the following table: Sales + 7% Gross Profits + 7% Operating Profits + 3% Earnin
Read more →UTMDSalt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its Board of Directors approved a quarterly cash dividend of eighteen cents ($.18) per share of common stock payable on
City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its of Directors approved a quarterly cash dividend of eighteen cents ($.18) share of common stock payable on April 5, 2006 to shareholders of record close of business on March 16, 2006. This is a six perce
Read more →UTMDSalt Lake City, Utah - In the fourth quarter (4Q) of 2005, Utah Medical Products, Inc.'s (Nasdaq: UTMD) consolidated sales were up 10%, gross profits up 14%, operating profits up 22%, net income up 36% and earnings per s
City, Utah - In the fourth quarter (4Q) of 2005, Utah Medical Products, Inc.'s (Nasdaq: UTMD) consolidated sales were up 10%, gross profits up 14%, operating profits up 22%, net income up 36% and earnings per share (eps) up 45%, compared increase in sales and gross profits ref
Read more →UTMDSalt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its legal counsel was notified today by Department of Justice legal counsel that the "Government is not appealing the Utah Medical decision
City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its counsel was notified today by Department of Justice legal counsel that the "Government is not appealing the Utah Medical decision." in reference to the October 21, 2005 Federal District Court decision d
Read more →UTMDSalt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) announces that on
City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) announces that on November 3, 2005 it concluded an annual surveillance audit to maintain its registration to ISO 13485, a set of well-accepted international quality standards for medical device manufacturers. The audit wa
Read more →UTMDSalt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its Board of Directors approved a quarterly cash dividend of seventeen cents ($.17) per share of common stock payable on
City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its of Directors approved a quarterly cash dividend of seventeen cents ($.17) share of common stock payable on January 5, 2006 to shareholders of record the close of business on December 16, 2005. This is a
Read more →UTMDSalt Lake City, Utah - The outcome of the U.S. Food & Drug Administration's (FDA or Agency) lawsuit filed in August 2004 was completely consistent with representations made since 2003 by Utah Medical Products, Inc. (UTMD
City, Utah - The outcome of the U.S. Food & Drug Administration's (FDA or Agency) lawsuit filed in August 2004 was completely consistent with representations made since 2003 by Utah Medical Products, Inc. (UTMD or Company) in its public disclosures. For interested parties, thi
Read more →UTMDSalt Lake City, Utah - Utah Medical Products, Inc. (UTMD) announces that the U.S. Federal District Court in Salt Lake City, on
City, Utah - Utah Medical Products, Inc. (UTMD) announces that the U.S. Federal District Court in Salt Lake City, on October 21, 2005, confirmed that UTMD operating in compliance with 21 CFR '820, U.S. Food & Drug Administration (FDA) Quality System Regulation (QSR). disagree
Read more →UTMDSalt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) announces that the trial for the lawsuit filed fourteen months ago by the Food and Drug Administration (FDA or Agency) in the U.S. District Court in Salt
City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) announces that the for the lawsuit filed fourteen months ago by the Food and Drug Administration (FDA or Agency) in the U.S. District Court in Salt Lake City, has concluded. has indicated that it would need a few days for
Read more →UTMDSalt Lake City, Utah - In the third quarter (3Q) of 2005, Utah Medical Products, Inc.'s (Nasdaq: UTMD) consolidated sales were up 5%, gross profits up 6%, operating profits down 20%, net income down 1% and earnings per s
City, Utah - In the third quarter (3Q) of 2005, Utah Medical Products, Inc.'s (Nasdaq: UTMD) consolidated sales were up 5%, gross profits up 6%, operating profits down 20%, net income down 1% and earnings per share (eps) up 13%, compared to 3Q 2004. increase in sales and gros
Read more →UTMDSalt Lake City, Utah - The trial of the lawsuit filed in August 2004 on behalf of the U.S. Food and Drug Administration (FDA) alleging Quality System Regulation (QSR) violations by Utah Medical Products, Inc. (Nasdaq: UT
City, Utah - The trial of the lawsuit filed in August 2004 on behalf of the Food and Drug Administration (FDA) alleging Quality System Regulation (QSR) violations by Utah Medical Products, Inc. (Nasdaq: UTMD) is scheduled to on September 26, 2005 in the U.S. District Court in
Read more →UTMDSalt Lake City, Utah - In the second calendar quarter (2Q) of 2005, Utah Medical Products, Inc.'s (Nasdaq: UTMD) consolidated sales were up 3%, gross profits up 2%, operating profits down 6%, net income up 2%, and earnin
City, Utah - In the second calendar quarter (2Q) of 2005, Utah Medical Products, Inc.'s (Nasdaq: UTMD) consolidated sales were up 3%, gross profits up 2%, operating profits down 6%, net income up 2%, and earnings per share (eps) up 16%, compared to 2Q 2004. profits were down
Read more →UTMDSalt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) announces that since the drop in its share price from $26.75 closing price on
utahmed8-k051905ex991.txt Salt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) announces that since the drop in its share price from $26.75 closing price on August 9, 2004 to $17.99 closing price on August 10, 2004, it has repurchased 539,000 shares in the open m
Read more →UTMDSalt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its Board of Directors approved a quarterly cash dividend of fifteen and one-half cents ($.155) per share of common stock payable on
utahmed8-k051105ex991.txt Salt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its Board of Directors approved a quarterly cash dividend of fifteen and one-half cents ($.155) per share of common stock payable on July 5, 2005 to shareholders of reco
Read more →UTMDSalt Lake City, Utah - In the first calendar quarter of 2005 (1Q 2005), Utah Medical Products, Inc. (Nasdaq:UTMD) continued excellent operating performance. According to Generally Accepted Accounting Principles (GAAP), U
utahmed8k042105ex99-1.txt Salt Lake City, Utah - In the first calendar quarter of 2005 (1Q 2005), Utah Medical Products, Inc. (Nasdaq:UTMD) continued excellent operating performance. According to Generally Accepted Accounting Principles (GAAP), UTMD's consolidated sales were
Read more →UTMDSalt Lake City, Utah - Utah Medical Products, Inc. (NASDAQ: UTMD) will release its financial results for the first quarter ending
utahmed8k041905ex99-1.txt Salt Lake City, Utah - Utah Medical Products, Inc. (NASDAQ: UTMD) will release its financial results for the first quarter ending March 31, 2005 (1Q 2005) near the stock market opening on Thursday, April 21, 2005, the 27th birthday of the According t
Read more →UTMDSalt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq:UTMD) is a defendant in a lawsuit filed more than five months ago by the Food and Drug Administration (FDA or Agency) in the U.S. District Court in Salt Lake Cit
utahmed8k012605ex99-1.txt Salt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq:UTMD) is a defendant in a lawsuit filed more than five months ago by the Food and Drug Administration (FDA or Agency) in the U.S. District Court in Salt Lake City, alleging violations of the
Read more →UTMDSalt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) is a defendant in a lawsuit filed four months ago by the Food and Drug Administration (FDA or Agency) in the U.S. District Court in Salt Lake City, allegi
utahmed8k121504ex99-1.txt Salt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) is a defendant in a lawsuit filed four months ago by the Food and Drug Administration (FDA or Agency) in the U.S. District Court in Salt Lake City, alleging violations of the Quality S
Read more →UTMDSalt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) is a defendant in a complaint filed by the Food and Drug Administration (FDA or Agency) on
utahmedicalex99-111604.txt Salt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) is a defendant in a complaint filed by the Food and Drug Administration (FDA or Agency) on August 9, 2004 with the U.S. District Court in Salt Lake City, alleging violations of the Qu
Read more →UTMDSalt Lake City, Utah - Since August 20, Utah Medical Products, Inc. (Nasdaq:UTMD) has recognized its loyal U.S. hospital customers who understand the clinical importance of using UTMD's high quality products with a speci
utahmedicalex99-1102104.txt Salt Lake City, Utah - Since August 20, Utah Medical Products, Inc. (Nasdaq:UTMD) has recognized its loyal U.S. hospital customers who understand the clinical importance of using UTMD's high quality products with a special 10% UTMD promised that th
Read more →UTMDThe reports of my death are greatly exaggerated." ...Mark Twain Salt Lake City, Utah - In August, Utah Medical Products, Inc. (Nasdaq:UTMD) published a number of its own press releases in response to an
utahmed8k101204ex99-1.txt "The reports of my death are greatly exaggerated." ...Mark Twain Salt Lake City, Utah - In August, Utah Medical Products, Inc. (Nasdaq:UTMD) published a number of its own press releases in response to an August 10, 2004 press release from the U.S. Fo
Read more →UTMDSalt Lake City, Utah - In the third calendar quarter of 2004 (3Q 2004), Utah Medical Products, Inc. (Nasdaq:UTMD) achieved 2% higher earnings per share (eps) compared to the same quarter in the prior year. Year-to-date (
utahmedicalex99-1101904.txt Salt Lake City, Utah - In the third calendar quarter of 2004 (3Q 2004), Utah Medical Products, Inc. (Nasdaq:UTMD) achieved 2% higher earnings per share (eps) compared to the same quarter in the prior year. Year-to-date (9M) eps from regular operati
Read more →Competitive Position
How UTMD ranks across every disease it competes inCompetitive Position is a premium feature
See how UTMD ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial